The strong revenue acceleration and narrowing losses confirm the aesthetic center expansion strategy is working. With Q3 guidance implying continued triple-digit growth in the core segment, traders should watch for the next quarterly report for potential profitability inflection. The stock's small cap and China exposure add volatility, but operational momentum is clearly positive.
Price Chart
Executive Summary
So-Young International reported Q2 2026 results with total revenue up 33.4% YoY to RMB505.2M, driven by a 129.5% surge in aesthetic treatment services revenue to RMB331.4M. Net loss attributable to the company narrowed 37% YoY to RMB22.7M, and Q3 guidance for aesthetic treatment revenue implies 91.7%-97.2% YoY growth. The company continues to scale its branded aesthetic center network with strong same-store sales growth of 52%.
Key Facts
- Total revenues RMB505.2M, up 33.4% YoY from RMB378.7M
- Aesthetic treatment services revenues RMB331.4M, up 129.5% YoY, exceeding high end of guidance
- Net loss attributable to So-Young narrowed to RMB22.7M from RMB36.0M YoY (37% improvement)
- Same-store sales growth of 52% vs 14% in Q2 2025
- Q3 2026 guidance: aesthetic treatment revenues RMB352M-RMB362M, representing 91.7%-97.2% YoY growth
- 65 branded aesthetic centers (63 directly-operated, 2 franchised) as of June 30, 2026; 47 achieved profitability in Q2
Financial Impact
Revenue growth of 33.4% YoY with aesthetic treatment revenue more than doubling; net loss reduced by 37% YoY; cash and equivalents of RMB848.2M ($125M) provide runway
Risk Factors
- Company remains unprofitable with net loss of RMB22.7M in Q2
- Declining information and reservation services revenue (-35% YoY) indicates platform monetization challenges
- China regulatory and macroeconomic risks for aesthetic treatment sector
- Short-term borrowings increased to RMB113.1M from RMB39.8M at year-end 2025
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001104659-26-103555 |
| Document: tm2624350d1_6k.htm | 0001104659-26-103555 |
| Document: 0001104659-26-103555-index-headers.html | 0001104659-26-103555 |
| Document: 0001104659-26-103555-index.html | 0001104659-26-103555 |
| Document: 0001104659-26-103555.txt | 0001104659-26-103555 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 31, 2026 8w ago | 6-K | $2.91 $2.71 | ▼ −6.87% | ▼ −6.69% | $2.12 (−27.15%) |
Aug 19, 2026 9w ago | Press Release | $2.39 $2.78 | ▲ +16.32% | ▲ +18.27% | $2.12 (−11.30%) |
Apr 23, 2026 26w ago | 20-F | $2.70 $2.63 | ▼ −2.59% | ▼ −7.23% | $2.12 (−21.48%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers